1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF): new trials by email Literature Review of Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) trials Research Report on Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF Elecoglipron, Placebo - Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | Phase 3 | Recruiting | AstraZeneca | 6950 | 2026-08-24 | 2026-09-28 |
Heart Failure (1)
Cardiovascular Diseases (1) · Heart Diseases (1)
AstraZeneca (1)
Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Canada (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Italy (1) · Japan (1)